I have read with great interest the paper of Dancey et al. entitled ‘Morphea of the breast. Two case reports and discussion of the literature’
1published in October 2006 in the Journal of Plastic, Reconstructive and Aesthetic Surgery. It reported two cases of localised scleroderma of the breast. In the first case there was no history of dermatological problems or precipitating factors. The patient underwent bilateral breast reduction and she remained disease free at 6 months follow up. The second patient developed the morphea following radiotherapy, but she decided to delay treatment. The authors showed a good result in the first case, but the same operation on the second patient would not be possible. I agree with the authors that no effective medical treatments exist for morphea, but there is another surgical option for selected cases. We reported
- Dancey A.L.
- Waters R.A.
Morphea of the breast. Two case reports and discussion of the literature.
J Plast Reconstr Aesthet Surg. 2006; 59: 1114-1117
2a case of a 36 year-old woman affected, since childhood, by a localised area of scleroderma of the left chest wall at the level of the fifth rib. Growth was unaffected until the onset of puberty and breast development, when a biopsy of the left chest wall confirmed the diagnosis of scleroderma. Subsequently the right breast continued to develop normally but the left breast had arrested growth of the inferior pole, resulting in the nipple being stuck to the chest wall at the inframammary crease and, therefore, gross breast asymmetry. When normal skin is grafted on to a recipient site involved in scleroderma, it becomes morphea-like over a period of 6 to 9 months, but skin involved in scleroderma when grafted to a healthy recipient site becomes normal.
- Armenio A.
- Hazari A.
- Smith R.W.
- et al.
Congenital scleroderma of the breast.
Plast Reconstr Surg. 2006; 117: 2524-2525
- Fries J.F.
- Hoopes J.E.
- Shulman L.E.
Reciprocal skin grafts in systemic sclerosis (scleroderma).
Arthritis Rheum. 1971; 14: 571-578
4However, transfer of free tissue is entirely unpredictable as there were no reports in the literature describing the use of free flaps into areas affected by scleroderma. In our case, almost 4 years after surgery there are no detectable changes in the DIEP flap. We believe that in selected cases, when surgery with local flaps is not possible, free tissue transfer is safe, reliable and will treat the disease.
- Haxthausen H.
Studies on the pathogenesis of morphea, vitiligo and acrodermatitis atrophicans by means of transplantation experiments.
Acta Derm Venereol. 1947; 27: 352-368
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Morphea of the breast. Two case reports and discussion of the literature.J Plast Reconstr Aesthet Surg. 2006; 59: 1114-1117
- Congenital scleroderma of the breast.Plast Reconstr Surg. 2006; 117: 2524-2525
- Reciprocal skin grafts in systemic sclerosis (scleroderma).Arthritis Rheum. 1971; 14: 571-578
- Studies on the pathogenesis of morphea, vitiligo and acrodermatitis atrophicans by means of transplantation experiments.Acta Derm Venereol. 1947; 27: 352-368
Published online: April 24, 2007
© 2007 Published by Elsevier Inc.